Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
TELA Bio, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TELA
Nasdaq
3850
www.telabio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for TELA Bio, Inc.
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
- Aug 19th, 2026 7:01 am
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...
- Aug 10th, 2026 11:03 pm
TELA Bio, Inc. Q2 2026 Earnings Call Summary
- Aug 10th, 2026 8:56 pm
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
- Aug 10th, 2026 3:55 pm
TELA Bio Reports Second Quarter 2026 Financial Results
- Aug 10th, 2026 2:05 pm
Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates
- Aug 6th, 2026 5:10 pm
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Aug 5th, 2026 2:05 pm
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
- Aug 4th, 2026 5:00 am
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
- Jul 29th, 2026 2:05 pm
TELA Bio to Announce Second Quarter 2026 Financial Results
- Jul 20th, 2026 2:05 pm
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25
- May 15th, 2026 6:11 am
TELA Bio, Inc. Q1 2026 Earnings Call Summary
- May 13th, 2026 6:30 am
TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...
- May 12th, 2026 11:01 pm
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates
- May 12th, 2026 3:15 pm
TELA Bio Reports First Quarter 2026 Financial Results
- May 12th, 2026 2:05 pm
BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates
- May 7th, 2026 3:25 pm
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
- Apr 30th, 2026 2:43 pm
TELA Bio to Announce First Quarter 2026 Financial Results
- Apr 21st, 2026 2:05 pm
Scroll